On another hand, metformin disrupts interaction between insulin/IGF-1R and G-protein-coupled receptor (GPCR) signaling pathways that have a critical role in the development of pancreatic cancer [133, 134]. This evidence concerns the gene IGF1R and familial pancreatic carcinoma.